Role of CRD-BP in the growth of human Basal Cell Carcinoma Cells

Although the number of new cases of Basal Cell Carcinoma (BCC) has increased rapidly in the last few decades, the molecular basis of its pathogenesis is not completely understood. Activation of Hedgehog (Hh) signaling pathway has been shown to be a key factor driving the development of BCC. The Wnt/β-catenin signaling pathway was also shown to be activated in BCCs and to perhaps modulate the activity of Hh pathway. We have previously identified a novel mechanism by which Wnt signaling regulates the transcriptional outcome of Hh signaling pathway. We demonstrated that CRD-BP, a direct target of the Wnt/β-catenin signaling, binds to GLI1 mRNA, stabilizes it, and consequently upregulates its levels (mRNA and protein) and activities. We hypothesized that Wnt-induced and CRD-BP-dependent regulation of GLI1 expression and activities is important to the development of BCC. In this study, we show that CRD-BP is over-expressed in BCC and that its expression positively correlates with the activation of both Wnt and Hh signaling pathways. We also describe the generation and characterization of a human BCC cell line. This cell line was utilized to demonstrate the importance of CRD-BP-dependent regulation of GLI1 expression and activities in the development of BCC.

[1]  R. Maestro,et al.  Alterations of beta-catenin pathway in non-melanoma skin tumors: loss of alpha-ABC nuclear reactivity correlates with the presence of beta-catenin gene mutation. , 2003, American Journal of Pathology.

[2]  M. Scott,et al.  Basal cell carcinomas in mice overexpressing sonic hedgehog. , 1997, Science.

[3]  N. Betz,et al.  The c-myc coding region determinant-binding protein: a member of a family of KH domain RNA-binding proteins. , 1998, Nucleic acids research.

[4]  B. Mannervik,et al.  Redesign of substrate-selectivity determining modules of glutathione transferase A1-1 installs high catalytic efficiency with toxic alkenal products of lipid peroxidation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[5]  C. Kittas,et al.  C‐MYC and IGF‐II mRNA‐binding protein (CRD‐BP/IMP‐1) in benign and malignant mesenchymal tumors , 2001, International journal of cancer.

[6]  D. Donoghue,et al.  Constitutive activation of the shh–ptc1 pathway by a patched1 mutation identified in BCC , 2005, Oncogene.

[7]  S. Fuchs,et al.  CRD-BP mediates stabilization of βTrCP1 and c-myc mRNA in response to β-catenin signalling , 2006, Nature.

[8]  I. Lemm,et al.  Overexpression of an mRNA-binding protein in human colorectal cancer , 2001, Oncogene.

[9]  D. Krause,et al.  Induction of basal cell carcinomas and trichoepitheliomas in mice overexpressing GLI-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[10]  V. Grachtchouk,et al.  Pathological responses to oncogenic Hedgehog signaling in skin are dependent on canonical Wnt/β-catenin signaling , 2008, Nature Genetics.

[11]  R. Maestro,et al.  Alterations of β-Catenin Pathway in Non-Melanoma Skin Tumors: Loss of α-ABC Nuclear Reactivity Correlates with the Presence of β-Catenin Gene Mutation , 2003 .

[12]  R. Poulsom,et al.  Expression of β‐catenin in basal cell carcinoma , 2003 .

[13]  D. Kuijpers,et al.  Basal Cell Carcinoma , 2002, American journal of clinical dermatology.

[14]  C. Wicking,et al.  The hedgehog signalling pathway in tumorigenesis and development , 1999, Oncogene.

[15]  N. Bhatia,et al.  Inhibition of β‐TrCP Function Potentiates UVB‐induced Apoptosis in hTERT‐immortalized Normal Human Keratinocytes † , 2008, Photochemistry and photobiology.

[16]  U. Dafni,et al.  8q24 Copy number gains and expression of the c‐myc mRNA stabilizing protein CRD‐BP in primary breast carcinomas , 2003, International journal of cancer.

[17]  K. Shigemasa,et al.  Increased expression of IGF II mRNA-binding protein 1 mRNA is associated with an advanced clinical stage and poor prognosis in patients with ovarian cancer. , 2004, International journal of oncology.

[18]  Michele Pagano,et al.  Wnt/β-Catenin Signaling Induces the Expression and Activity of βTrCP Ubiquitin Ligase Receptor , 2000 .

[19]  E. Epstein.  Basal cell carcinomas: attack of the hedgehog , 2008, Nature Reviews Cancer.

[20]  K. Kawakami,et al.  Wnt signaling stimulates transcriptional outcome of the Hedgehog pathway by stabilizing GLI1 mRNA. , 2009, Cancer research.

[21]  G. Nasioulas,et al.  Expression of the RNA-binding protein CRD-BP in brain and non-small cell lung tumors. , 2004, Cancer letters.

[22]  S. Fuchs,et al.  CRD-BP mediates stabilization of betaTrCP1 and c-myc mRNA in response to beta-catenin signalling. , 2006, Nature.

[23]  Rippey.  Why classify basal cell carcinomas? , 1998, Histopathology.

[24]  C. Steer,et al.  Developmental regulation of CRD-BP, an RNA-binding protein that stabilizes c-myc mRNA in vitro , 1997, Oncogene.

[25]  Q. Gu,et al.  Activating Smoothened mutations in sporadic basal-cell carcinoma , 1998, Nature.

[26]  R. Poulsom,et al.  Expression of beta-catenin in basal cell carcinoma. , 2003, The British journal of dermatology.

[27]  C. Hui,et al.  Basal cell carcinomas in mice overexpressing Gli2 in skin , 2000, Nature Genetics.

[28]  U. Dafni,et al.  CRD-BP: a c-Myc mRNA stabilizing protein with an oncofetal pattern of expression. , 2003, Anticancer research.

[29]  Hong Zhang,et al.  Ornithine decarboxylase is a target for chemoprevention of basal and squamous cell carcinomas in Ptch1+/- mice. , 2004, The Journal of clinical investigation.

[30]  T. Slaga,et al.  Wnt/beta-catenin signaling induces the expression and activity of betaTrCP ubiquitin ligase receptor. , 2000, Molecular cell.

[31]  V. Adhami,et al.  Inhibition of CWR22Rnu1 tumor growth and PSA secretion in athymic nude mice by green and black teas. , 2006, Carcinogenesis.